000989.SZ
九芝堂
SZSE · Healthcare · C 制造业 · CN
CNY 8.66
−4.20%Year over year
Reported trailing growth
- Revenue
- +14.3%
- EBITDA
- —
- EBIT
- +78.3%
- EPS
- +44.4%
- Free cash flow
- -10.2%
- Operating cash flow
- -12.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -9.8%
- EBITDA
- -10.1%
- EBIT
- -12.2%
- Net income
- -14.6%
- EPS
- -14.3%
- Free cash flow
- -1.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026